Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

000766 Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.

Trading 08-11 14:37:03

16.80

-0.51

-2.95%

High17.33	Low16.79	Vol18.01M
Open17.21	D1 Closing17.31	Amplitude3.12%
Mkt Cap16.23B	Tradable Cap16.23B	Total Shares966.00M
T/O306.00M	T/O Rate1.86%	Tradable Shares966.00M
P/B7.21	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"000766","market":"SZ","secType":"STK","nameCN":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.","latestPrice":16.8,"timestamp":1786430223000,"preClose":17.31,"halted":0,"volume":18013372,"delay":0,"changeRate":-0.0295,"floatShares":966000000,"shares":966000000,"eps":0.033,"marketStatus":"Trading","change":-0.51,"latestTime":"08-11 14:37:03","open":17.21,"high":17.33,"low":16.79,"amount":306000000,"amplitude":0.0312,"askPrice":16.8,"askSize":294,"bidPrice":16.79,"bidSize":168,"shortable":0,"etf":0,"ttmEps":0.033,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786431600000},"marketStatusCode":2,"adr":0,"adjPreClose":17.31,"symbolType":"stock","openAndCloseTimeList":[[1786411800000,1786419000000],[1786424400000,1786431600000]],"highLimit":19.04,"lowLimit":15.58,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":966494707,"isCdr":false,"pbRate":7.21,"roa":"--","peRate":509.090909,"roe":"0.39%","epsLYR":0.04,"committee":0.470149,"marketValue":16237000000,"turnoverRate":0.0186,"status":1,"floatMarketCap":16229000000},"requestUrl":"/m/hq/s/000766/tweets","defaultTab":"tweets","newsList":[{"id":"2657961401","title":"Tonghua Golden-Horse Signs Non-Binding Acquisition Agreement to Purchase Drug Research Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2657961401","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657961401?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:08","pubTimestamp":1786097303,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry  signed a non-binding agreement to purchase a controlling stake in Bajiayi Pharmaceutical, according to a Friday filing with the Shenzhen bourse.Bajiayi is a pharmaceutical research company with 23 drug research and development patents.The agreement has a 90-day exclusivity agreement, which would not allow Bajiayi to entertain acquisition negotiations with other parties.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0077","BK0060","000766","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103242279","title":"Tonghua Golden-Horse Plans to Acquire Majority Stake in Eight Plus One Pharma to Strengthen Neurological Disease Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1103242279","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103242279?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:08","pubTimestamp":1786014514,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) has announced that its wholly-owned subsidiary, Guilin Golden-Horse Innovation Investment Co., Ltd. (referred to as \"Guilin...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0077","000766","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648098511","title":"Golden-Horse Pharmaceutical Chair Pledges to Buy Up to 20 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648098511","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648098511?lang=en_us&edition=fundamental","pubTime":"2026-07-01 18:03","pubTimestamp":1782900231,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry  said Chair and General Manager Zhang Yufu plans to increase his stake by 10 million yuan to 20 million yuan within six months, following the drug registration of ambuciamide succinate tablets on June 25.Zhang, who currently holds 0.05% of the company, previously completed a similar buyback in March, according to a Wednesday filing with the Shenzhen bourse.Shares of the drug company closed 2% lower Wednesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0060","000766","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648511561","title":"Tonghua Golden-Horse Pharmaceutical Industry's Stock Fluctuates More Than 20% for Two Straight Trading Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2648511561","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648511561?lang=en_us&edition=fundamental","pubTime":"2026-07-01 17:46","pubTimestamp":1782899176,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry's  stock fluctuated more than 20% for two straight trading sessions on June 29 and 30, according to a Wednesday filing with the Shenzhen bourse.The stock movement coincided with the approval of its anveracrine succinate tablets for mild to moderata Alzheimer's, the filing said.Shares closed 2% lower on Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["000766","BK0077","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134283892","title":"Key Market Announcements and Trading Alerts for July 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1134283892","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134283892?lang=en_us&edition=fundamental","pubTime":"2026-07-01 07:47","pubTimestamp":1782863252,"startTime":"0","endTime":"0","summary":"This article provides a summary of significant corporate announcements and trading actions for July 1, 2026. Trading Halts and Resumptions Several companies have announced trading suspensions. ST...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245177.USD","BK0065","BK0185","BK0094","600233","BK0148","LU1997244956.HKD","BK0014","BK0235","600892","BK0257","300861","BK0018","BK0058","LU2289578879.USD","BK0057","BK0277","BK0177","002313","002628","001373","BK0188","BK0155","BK0217","000017","BK0060","BK0095","BK0232","BK0224","IE00BYTNYN87.SGD","BK0153","603389","BK0167","000420","BK0089","BK0229","BK0071","BK0251","BK0260","BK0182","BK0195","300573","603580","BK0201","BK0174","BK0175","BK0271","BK0111","688012","BK0070","603559","BK0139","IE00B12V2V27.USD","BK0132","603137","BK0259","603789","BK0147","688571","BK0233","BK0220","BK0075","688319","688260","BK0102","LU1997245094.SGD","BK0165","BK0208","BK0086","BK0030","BK0000","LU2211815571.USD","BK0041","BK0006","BK0214","002326","601766","BK0194","002106","BK0077","301248","000595","000021","BK0231","BK0005","BK0003","300302","LU2495084118.USD","BK0012","000601","002653","BK0044","BK0108","002635","BK0100","002625","000656","BK0098","BK0002","BK0197","002458","BK0226","BK0010","IE00BYQNZ168.SGD","LU0593848301.USD","000767","BK0198","BK0196","BK0279","605020","002738","BK0033","BK0239","BK0076","BK0138","BK0183","BK0152","688408","BK0028","BK0123","300179","BK0090","BK0103","BK0273","BK0240","002943","600872","01766","600728","BK0261","BK0072","000766","BK0133","300368"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149943923","title":"Tonghua Golden-Horse Chairman and General Manager Plans Share Purchase Worth 10 to 20 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1149943923","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149943923?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:01","pubTimestamp":1782828079,"startTime":"0","endTime":"0","summary":"On the evening of June 30th, Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SZSE: 000766) released an announcement disclosing a planned share purchase by its leadership. The company stated...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0077","BK0239","BK0060","000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646933422","title":"Golden-Horse Pharma Secures Registration Certificate for Anveracrine Succinate Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2646933422","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646933422?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:24","pubTimestamp":1782458652,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical (SHE:000766) obtained a drug registration certificate for anveracrine succinate tablets, according to a Shenzhen bourse filing on Friday.The drug is used for the treatment of symptoms of mild-to-moderate Alzheimer's disease.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["000766","BK0239","BK0077","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156401798","title":"Golden-Horse Pharmaceutical Receives Regulatory Approval for New Alzheimer's Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1156401798","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156401798?lang=en_us&edition=fundamental","pubTime":"2026-06-25 15:48","pubTimestamp":1782373719,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SHE: 000766) has announced that it has received the Drug Registration Certificate from the National Medical Products Administration for its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000766","BK0239","BK0060","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113558502","title":"Tonghua Golden-Horse Reports Q1 Net Profit Attributable to Shareholders of 9.13 Million Yuan, Down 21.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113558502","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113558502?lang=en_us&edition=fundamental","pubTime":"2026-04-27 22:40","pubTimestamp":1777300827,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) has released its financial results for the first quarter of 2026. During the quarter, the company achieved operating revenue of 300...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000766","BK0077","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629013440","title":"Tonghua Golden-Horse Pharmaceutical's Attributable Profit Slides 39% in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2629013440","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629013440?lang=en_us&edition=fundamental","pubTime":"2026-04-22 16:15","pubTimestamp":1776845750,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical's  attributable profit fell 39% to 34.3 million yuan in 2025 from 56.4 million yuan in 2024, according to a Wednesday filing with the Shenzhen bourse.Earnings per share at the drug company decreased 33% to 0.04 yuan from 0.06 yuan in the previous year.Operating income declined 12% year over year to 1.17 billion yuan from 1.32 billion yuan.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["000766","BK0060","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129829413","title":"Tonghua Golden-Horse Reports 2025 Net Profit of 34.29 Million Yuan, Down 39.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129829413","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129829413?lang=en_us&edition=fundamental","pubTime":"2026-04-21 17:56","pubTimestamp":1776765410,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) has released its annual report for 2025. During the reporting period, the company achieved operating revenue of 1.17 billion yuan,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000766","BK0077","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107371628","title":"Tonghua Golden-Horse Pharmaceutical Advances Commercialization Efforts for New Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1107371628","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107371628?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:40","pubTimestamp":1774276832,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. stated on March 23, in response to investor inquiries on an interactive platform, that the company is actively advancing work related to the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000766","BK0239","BK0077","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107442592","title":"Tonghua Golden-Horse Chairman and CEO Plans Share Purchase Worth Up to 20 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1107442592","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107442592?lang=en_us&edition=fundamental","pubTime":"2026-03-03 17:33","pubTimestamp":1772530381,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) announced that its Chairman and General Manager, Mr. Zhang Yufu, intends to increase his holdings in the company's shares. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000766","BK0239","BK0077","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101841410","title":"Tonghua Golden-Horse to Announce 2025 Financial Results in Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1101841410","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101841410?lang=en_us&edition=fundamental","pubTime":"2026-02-26 22:20","pubTimestamp":1772115648,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. stated on February 26 in response to an investor inquiry on an interactive platform that its operating performance for the 2025 fiscal year will...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0077","000766","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123083908","title":"New Drug from Tonghua Golden-Horse Advances to Final Review Stage, Recent Performance Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1123083908","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123083908?lang=en_us&edition=fundamental","pubTime":"2026-02-14 13:31","pubTimestamp":1771047071,"startTime":"0","endTime":"0","summary":"According to the latest disclosure by Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. on an investor interaction platform, the company's Class 1 new chemical drug, Succinyl...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0077","BK0060","000766","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786430224802,"stockEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":0.0491},{"period":"3month","weight":-0.2523},{"period":"6month","weight":-0.2568},{"period":"1year","weight":-0.2265},{"period":"ytd","weight":-0.3703}],"compareEarnings":[{"period":"1week","weight":0.0412},{"period":"1month","weight":-0.0074},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.04},{"period":"1year","weight":0.0912},{"period":"ytd","weight":-0.0006}],"compareStock":{"symbol":"000001.SH","name":"SSE Comp"},"companyName":"通化金马药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"43008人(较上一季度增加24.28%)","perCapita":"22461股","listingDate":"1997-04-30","address":"吉林省通化市二道江区金马路999号","registeredCapital":"96649万元","survey":"　　通化金马药业集团股份有限公司的主营业务是医药产品的研发、生产与销售。公司的主要产品是复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾颗粒、芩石利咽口服液、乳酸亚铁口服液。经历多年发展，公司获得行业认可，2024年荣获“黑龙江省质量标杆”、“哈尔滨市民营科技创新企业30强”、“哈尔滨市民营制造业企业50强”，2025年评为黑龙江省绿色工厂等称号。子公司永康制药近些年荣获“国家高新技术企业”、“国家知识产权优势企业”、“四川省企业技术中心”、“四川省专精特新中小企业”、“成都市科技企业”、温江区优秀企业（50强）等称号。","listedPrice":7.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.,000766,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票老虎,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票老虎国际,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.行情,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票行情,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股价,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股市,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票价格,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票交易,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票购买,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction